# Lilly France S.A.S. – FDA Inspection, Feb 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/lilly-france-sas/107930e4-af02-49fc-acbe-092ab003f224
Source feed: FDA_Inspections

> FDA inspection 1081382 of Lilly France S.A.S., February 19, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081382
- Company Name: Lilly France S.A.S.
- Inspection Date: 2019-02-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- FDA Inspection 1299456 - 2023-09-29
- FDA Inspection 1180181 - 2021-01-15
- FDA Inspection 1117961 - 2020-01-16
- [FDA Inspection 1063854 - 2018-08-28](https://www.keypedia.com/records/fda_inspections/lilly-france-sas/f327e9ea-160b-4d12-8602-054ba10008d1)
- [FDA Inspection 1020863 - 2017-04-04](https://www.keypedia.com/records/fda_inspections/lilly-france-sas/e5ccc457-4508-4a84-a212-24a4fa072cb5)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)

Company: https://www.keypedia.com/companies/lilly-france-sas/27fa7368-5fb0-48b1-b161-5729c7bfa061

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8